Aurinia Pharmaceuticals AUPH Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's share-based payment award options outstanding - number?
- Aurinia Pharmaceuticals (AUPH) reported share-based payment award options outstanding - number of 9.3M in Q1 2026.
- How has Aurinia Pharmaceuticals's share-based payment award options outstanding - number changed year-over-year?
- Aurinia Pharmaceuticals's share-based payment award options outstanding - number decreased by 16.1% year-over-year, from 11.1M to 9.3M.
- What is the long-term trend for Aurinia Pharmaceuticals's share-based payment award options outstanding - number?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's share-based payment award options outstanding - number has grown at a -7.1% compound annual growth rate (CAGR), from 12.1M to 9M.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.